Microstructural white matter brain abnormalities in patients with idiopathic fecal incontinence

2017 ◽  
Vol 30 (1) ◽  
pp. e13164
Author(s):  
J. Muthulingam ◽  
S. Haas ◽  
T. M. Hansen ◽  
S. Laurberg ◽  
L. Lundby ◽  
...  
2009 ◽  
Vol 52 (2) ◽  
pp. 293-298 ◽  
Author(s):  
Felix Aigner ◽  
Friedrich Conrad ◽  
Raimund Margreiter ◽  
Michael Oberwalder

2015 ◽  
Vol 36 (1) ◽  
pp. 26-39 ◽  
Author(s):  
Reinhold Schmidt ◽  
Stephan Seiler ◽  
Marisa Loitfelder

Knowledge about the longitudinal change of cerebral small-vessel disease–related magnetic resonance imaging abnormalities increases our pathophysiologic understanding of cerebral microangiopathy. The change of specific lesion types may also serve as secondary surrogate endpoint in clinical trials. A surrogate endpoint needs to progress fast enough to allow monitoring of treatment effects within a reasonable time period, and change of the brain abnormality needs to be correlated with clinical change. Confluent white matter lesions show fast progression and correlations with cognitive decline. Thus, the change of confluent white matter lesions may be used as a surrogate marker in proof-of-concept trials with small patient numbers needed to show treatment effects on lesion progression. Nonetheless if the expected change in cognitive performance resulting from treatment effects on lesion progression is used as outcome, the sample size needed to show small to moderate treatment effects becomes very large. Lacunes may also fulfill the prerequisites of a surrogate marker, but in the general population the incidence of lacunes over short observational periods is small. For other small-vessel disease–related brain abnormalities including microbleeds and microstructural changes in normal-appearing white matter longitudinal change and correlations with clinical decline is not yet fully determined.


1994 ◽  
Vol 37 (1) ◽  
pp. 42-48 ◽  
Author(s):  
Ragnhild Emblem ◽  
Gonda Dhaenens ◽  
Ragnar Stien ◽  
Lars Mørkrid ◽  
Ansgar O. Aasen ◽  
...  

2000 ◽  
Vol 43 (5) ◽  
pp. 633-636 ◽  
Author(s):  
Ole Ø. Rasmussen ◽  
John Christiansen ◽  
Tine Tetzschner ◽  
Michael Sørensen

2001 ◽  
Vol 44 (5) ◽  
pp. 666-671 ◽  
Author(s):  
B.Ó C. Súilleabháin ◽  
A. F. Horgan ◽  
L. McEnroe ◽  
F. W. Poon ◽  
J. H. Anderson ◽  
...  

2015 ◽  
Vol 27 (7) ◽  
pp. 954-962 ◽  
Author(s):  
S. Haas ◽  
C. Brock ◽  
K. Krogh ◽  
M. Gram ◽  
L. Lundby ◽  
...  

2001 ◽  
Vol 178 (5) ◽  
pp. 412-419 ◽  
Author(s):  
Therese Van Amelsvoort ◽  
Eileen Daly ◽  
Dene Robertson ◽  
John Suckling ◽  
Virginia Ng ◽  
...  

BackgroundVelo-cardio-facial syndrome (VCFS) is associated with deletions in the q11 band of chromosome 22, learning disability and psychosis, but the neurobiological basis is poorly understood.AimsTo investigate brain anatomy in adults with VCFS.MethodMagnetic resonance imaging was used to study 10 patients with VCFS and 13 matched controls. We carried out three analyses: qualitative; traced regional brain volume; and measurement of grey and white matter volume.ResultsThe subjects with VCFS had: a high prevalence of white matter hyperintensities and abnormalities of the septum pellucidum; a significantly smaller volume of cerebellum; and widespread differences in white matter bilaterally and regional specific differences in grey matter in the left cerebellum, insula, and frontal and right temporal lobes.ConclusionsDeletion at chromosome 22q11 is associated with brain abnormalities that are most likely neurodevelopmental and may partially explain the high prevalence of learning disability and psychiatric disorder in VCFS.


Sign in / Sign up

Export Citation Format

Share Document